Keywords: AFF, atypical femoral fractures; AGE, advanced glycation end-products; ASBMR, American Society for Bone and Mineral Research; BMU, basic multi-cellular unit; BP, bisphosphonate; Cx43, connexin 43; DEXA, dual energy x-ray absorptiometry; E, elastic modulus
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: BP, bisphosphonate; ZOL, zoledronic acidZoledronic acid; Tooth eruption; Skull bone formation; Osteosarcoma
Keywords: BP, Bisphosphonate; AFF, Atypical femur fracture; KPNC, Kaiser Permanente Northern California; ICD-9, International Classification of Diseases, Ninth RevisionFemur fracture; Subtrochanter; Femoral shaft; Atypical fracture; Bisphosphonates
Correlation of baseline biomarkers with clinical outcomes and response to fulvestrant with vandetanib or placebo in patients with bone predominant metastatic breast cancer: An OCOG ZAMBONEY sub-study
Keywords: BP, bisphosphonate; BPI, brief pain inventory; CTx, C-telopeptide; ER, estrogen receptor; FACT-BP, Functional assessment of cancer therapy-bone pain; OS, overall survival; PFS, progression free survival; PR, progesterone receptor; RANKL, Receptor Activato
On-cartridge derivatization coupled with solid-phase extraction for the ultra-sensitive determination of minodronic acid in human plasma by LC–MS/MS method
Keywords: AA, alendronic acid; BP, bisphosphonate; D4-MA, D4-minodronic acid; HQC, high QC; IMF, IS-normalized matrix factor; IS, internal standard; LLOQ, lower limit of quantification; LQC, low QC; MA, minodronic acid; MQC, medium QC; MRM, multiple reaction monito
Specific features of HIV-1 integrase inhibition by bisphosphonate derivatives
Keywords: HIV; Integrase; Bisphosphonates; Inhibitors; SARHAART, highly active antiretroviral therapy; IN, integrase; BP, bisphosphonate; INSTI, integrase strand transfer inhibitor; LEDGF, lens epithelium derived growth factor; RT, reverse transcriptase; VDPA, viny
Infrared, Raman and NMR investigations of risedronate adsorption on nanocrystalline apatites
Keywords: BP, bisphosphonate; NCA, nanocrystalline apatite; HA, well crystallised stoichiometric hydroxyapatiteAdsorption; Bisphosphonate; Hydroxyapatite; Nanocrystalline apatite; Risedronate; Spectroscopy
Pyrophosphates as a major inhibitor of matrix calcification in Pseudoxanthoma elasticum
Keywords: ABCC6, ATP-binding cassette subfamily C member 6; ALP, Non-tissue specific alkaline phosphate; BP, Bisphosphonate; ENPP1, Ectonucleotide pyrophospatase 1; FPP, Farnesylpyrophosphate; GGPP, Geranylgeranylpyrophosphate; NHDF, Normal human dermal fibroblast;
Synthesis and characterization of novel phosphonocarboxylate inhibitors of RGGT
Keywords: Phosphonocarboxylates; Bisphosphonates; Geranylgeranylation; RGGT; GGPPSPC, phosphonocarboxylate; BP, bisphosphonate; RGGT, Rab geranylgeranyl transferase, Rab GGTase, GGTase 2; TAG tunnel, a tunnel adjacent to GGPP binding site in RGGT; FTase, farnesyl t
Mevalonate pathway intermediates downregulate zoledronic acid-induced isopentenyl pyrophosphate and ATP analog formation in human breast cancer cells
Keywords: AppCCl2p, 5′(β,γ-dichloromethylene) triphosphate; ApppI, triphosphoric acid 1-adenosin-5′-yl ester 3-(3-methylbut-3-enyl) ester; ApppD, triphosphoric acid 1-adenosin-5′-yl ester 3-(3-methylbut-2-enyl) ester; BP, bisphosphonate; CLOD, clodronate; DMAPP, di
The effect of anti-resorptive therapies on bone graft healing in an ovariectomized rat spinal arthrodesis model
Keywords: ALP, alkaline phosphatase; BP, bisphosphonate; BV/TV, bone volume/tissue volume; CgV/TV, endochondral cartilaginous matrix volume/tissue volume; Conn. D, connective density; CTR, calcitonin receptor; CTX, type I collagen crosslinked C-telopeptides; ELISA,
Relative binding affinities of bisphosphonates for human bone and relationship to antiresorptive efficacy
Keywords: ALN, alendronate; BP, bisphosphonate; CL2, clodronate; CTX, C-telopeptides; EHDP, etidronate; IBA, ibandronate; N-BPs, μM, micromolar, nitrogen-containing bisphosphonates; OH-BPs, hydroxyl-bearing bisphosphonates; PAM, pamidronate; RIS, risedronate; ZOL,